(19)
(11) EP 1 543 019 A2

(12)

(88) Date of publication A3:
29.04.2004

(43) Date of publication:
22.06.2005 Bulletin 2005/25

(21) Application number: 03794821.3

(22) Date of filing: 11.09.2003
(51) International Patent Classification (IPC)7C07H 21/00, A61K 31/7052
(86) International application number:
PCT/DK2003/000588
(87) International publication number:
WO 2004/024757 (25.03.2004 Gazette 2004/13)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 11.09.2002 DK 200201334
19.11.2002 DK 200201786
20.12.2002 DK 200201956
16.04.2003 DK 200300600

(71) Applicant: Santaris Pharma A/S
2970 Horsholm (DK)

(72) Inventors:
  • RASMUSSEN, Palle
    DK-2880 Bagsvaerd (DK)
  • FRANDSEN, Niels, Montano
    DK-2100 Copenhagen (DK)
  • NYBORG, Marlene
    DK-1920 Frederiksberg C (DK)
  • RASMUSSEN, Frank, Winther
    DK-1620 Copenhagen V (DK)
  • HAMZAVI, Ramin
    DK-2400 Copenhagen NV (DK)
  • NIELSEN, Peter, Eigild
    DK-2980 Kokkedal (DK)
  • KJAERULFF, Soren
    DK-2840 Holte (DK)

(74) Representative: Olsen, Lars Pallisgaard et al
Zacco Denmark A/SHans Bekkevolds Allé 7
2900 Hellerup
2900 Hellerup (DK)

   


(54) MODIFIED PNA MOLECULES